End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
833.00 TWD | -1.30% |
|
+5.44% | +10.77% |
Chart calendar Bora Pharmaceuticals Co., LTD.
d.QDzc-lcBvXxPwvmdBO3UFfFb0TAAwQGJTx3oVKtiS0U.B36ujjRn7iYMuqivbIycXpVri0Z2rXG7A167NdEOcnQybY6LJ1PLE2Kkjg~5489454605743f03373d90a37b418f6e
Upcoming events on Bora Pharmaceuticals Co., LTD.
Past events on Bora Pharmaceuticals Co., LTD.
Past dividends on Bora Pharmaceuticals Co., LTD.
2025-06-19 | Annual 14 TWD |
2024-08-11 | Annual 12 TWD |
2023-07-05 | Annual 8 TWD |
2022-07-06 | Annual 3.5 TWD |
2021-09-06 | Annual 2 TWD |
2020-07-05 | Annual 2 TWD |
2019-07-30 | Annual 3 TWD |
2018-07-15 | Annual 0.499519 TWD |
2017-07-24 | Annual 0.8 TWD |
2016-07-17 | Annual 0.601984 TWD |
2015-09-02 | Annual 0.5 TWD |
Annual results
Fiscal Period | December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Net sales Million TWD | Released Forecast Spread | 10 494 10 401 0.9% | 14 200 14 195 0.04% | 19 246 19 179 0.35% | 22 877 | 28 524 | 37 787 |
EBITDA Million TWD | Released Forecast Spread | 2 263 2 964 -23.67% | 5 855 5 844 0.2% | 4 409 5 170 -14.72% | 6 299 | 7 698 | 10 872 |
EBIT Million TWD | Released Forecast Spread | 1 922 2 404 -20.03% | 5 249 5 373 -2.31% | 3 383 4 211 -19.66% | 5 532 | 7 129 | 10 044 |
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | 1 840 2 543 -27.64% | 4 064 4 268 -4.77% | 4 955 5 418 -8.54% | 8 399 | 6 619 | 9 539 |
Net income Million TWD | Released Forecast Spread | 1 392 1 803 -22.78% | 3 030 3 121 -2.92% | 3 939 4 236 -7.02% | 5 324 | 5 118 | 7 582 |
EPS TWD | Released Forecast Spread | 14,1 18,4 -23.62% | 30,2 31,8 -4.98% | 38,7 40,9 -5.31% | 51,0 | 48,8 | 69,1 |
Announcement Date | 20/03/23 | 07/03/24 | 05/03/25 | - |
Quarterly results
Fiscal Period | March | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million TWD | Released Forecast Spread | 3 075 3 110 -1.1% | 3 206 3 201 0.14% | 2 857 2 857 0.02% | 5 027 4 896 2.69% | 5 615 5 156 8.9% | 5 746 5 816 -1.2% | 4 480 5 123 -12.56% | 5 588 | 6 103 | 6 393 | 6 681 | 7 566 | 8 101 | 7 757 |
EBITDA Million TWD | Released Forecast Spread | 1 370 1 492 -8.2% | 1 320 1 281 3.05% | 1 083 1 293 -16.21% | 994 1 813 -45.16% | 1 473 1 782 -17.33% | 858 1 763 -51.32% | 975 1 397 -30.24% | 1 710 | 2 032 | 2 185 | 2 140 | 2 430 | 2 450 | 2 135 |
EBIT Million TWD | Released Forecast Spread | 1 219 1 304 -6.51% | 1 320 1 263 4.56% | 892 1 004 -11.11% | 743 1 371 -45.82% | 1 217 1 322 -7.94% | 531 1 380 -61.55% | 681 946 -28% | 1 200 | 1 495 | 1 639 | 1 657 | 1 944 | 2 112 | 2 003 |
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | 923 1 031 -10.43% | 680 886 -23.27% | 984 699 40.71% | 1 512 1 235 22.41% | 1 716 1 125 52.61% | 743 1 299 -42.8% | 3 017 3 348 -9.87% | 1 361 | 1 693 | 1 560 | 1 585 | 1 869 | 2 035 | 1 925 |
Net income Million TWD | Released Forecast Spread | 733 659 11.21% | 566 660 -14.3% | 716 511 40.28% | 1 172 930 25.95% | 1 447 812 78.26% | 604 975 -38% | 1 399 2 829 -50.53% | 652 | 1 601 | 1 356 | 1 235 | 1 458 | 1 587 | 1 497 |
EPS TWD | Released Forecast Spread | 7,28 6,65 9.54% | 6,09 6,54 -6.92% | 6,88 5,03 36.78% | 11,3 9,19 22.58% | 14,2 8,01 76.76% | 5,82 9,50 -38.7% | 12,7 27,6 -53.79% | 6,28 | 15,5 | 13,1 | 11,9 | 14,1 | 15,3 | 14,5 |
Announcement Date | 09/11/23 | 07/03/24 | 14/05/24 | 13/08/24 | 13/11/24 | 05/03/25 | 13/05/25 | - | - | - | - | - | - | - |
2025-07-15 | GLAND PHARMA LIMITED: Q1 2026 Earnings Release (Projected) |
2025-07-16 06:45 am | JOHNSON & JOHNSON: Q2 2025 Earnings Release |
2025-07-16 | NOVARTIS AG: Q2 2025 Earnings Release |
2025-07-17 01:00 am | CAMURUS AB: Q2 2025 Earnings Release |
2025-07-17 | JUBILANT PHARMOVA LIMITED: Q1 2026 Earnings Release (Projected) |
2025-07-18 05:00 am | ORION OYJ: Q2 2025 Earnings Release |
2025-07-22 | DR. REDDY'S LABORATORIES LIMITED: Q1 2026 Earnings Release |
2025-07-22 | LABORATORIOS FARMACEUTICOS ROVI, S.A.: Q2 2025 Earnings Release (Projected) |
2025-07-22 | GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.: Q2 2025 Earnings Release |
2025-07-23 01:00 am | COSMO PHARMACEUTICALS N.V.: Q2 2025 Earnings Release |
Past sector events for Bora Pharmaceuticals Co., LTD.
2025-07-10 04:22 am | LOTUS PHARMACEUTICAL CO., LTD.: June 2025 Sales and Revenue Release |
2025-07-09 07:51 pm | BORA PHARMACEUTICALS CO., LTD.: June 2025 Sales and Revenue Release |
2025-07-09 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release |
2025-07-09 04:26 am | YUNGSHIN GLOBAL HOLDING CORPORATION: June 2025 Sales and Revenue Release |
2025-07-09 04:06 am | CALIWAY BIOPHARMACEUTICALS CO., LTD.: June 2025 Sales and Revenue Release |
2025-07-09 01:58 am | SYNMOSA BIOPHARMA CORPORATION: June 2025 Sales and Revenue Release |
2025-07-02 04:08 am | ONENESS BIOTECH CO., LTD.: June 2025 Sales and Revenue Release |
2025-06-17 11:45 am | MEDINCELL S.A.: Q4 2025 Earnings Release |
2025-06-10 04:38 am | LOTUS PHARMACEUTICAL CO., LTD.: May 2025 Sales and Revenue Release |
2025-06-10 01:42 am | CENTER LABORATORIES, INC.: May 2025 Sales and Revenue Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 6472 Stock
- Calendar Bora Pharmaceuticals Co., LTD.
Select your edition
All financial news and data tailored to specific country editions